Global Pregabalin Market: Industry Analysis and Forecast (2020-2026) By Product, Application and Region

Global Pregabalin Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 3.5% during forecast period.

Global Pregabalin Market Overview:

Pregabalin is an anticonvulsant and anxiolytic medicine used to treat epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, and generalised anxiety disorder, among other conditions. It is used as an add-on therapy for partial seizures in epilepsy. It decreases pain but causes more drowsiness and visual abnormalities when administered before surgery.

Global Pregabalin Market Dynamics:

Rising Incidences of Diabetes and HIV is the major factor driving the market growth.

The global prevalence of epilepsy, neuropathic pain, and other related illnesses are driving the industry. Furthermore, market growth is expected to be fuelled by the growing geriatric population, as well as the rising prevalence of diabetes, neuropathic pain, fibromyalgia, and other diseases. Epilepsy is a brain condition that affects people of all ages and is a chronic non-communicable disease. Epilepsy affects almost 50 million individuals worldwide, making it one of the most common neurological diseases. In the early stages of epilepsy, 80% of patients reside in low- and middle-income nations. However, the global pregabalin market will be boosted by an increase in the incidence rate of cardiac, kidney, liver, and type II diabetes. Furthermore, the engagement of key companies in R&D production, various healthcare investments, and a number of product releases gloves give opportunistic opportunities in the development of the pregabalin market in the area. Various health concerns have prompted the government to enact regulatory procedures and levy taxes on the manufacture and distribution of Pregabalin in the drug market in recent years. During the forecast period, this is expected to fuel market growth. The FDA's clearance of generic copies of the drug, on the other hand, boosts drug availability but decreasing market revenue. Pregabalin's growth is also projected to be hampered by the availability of alternatives, side effects, and strict regulatory rules. The report has profiled twenty three key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Pregabalin Market Segment Analysis:

The Global Pregabalin Market is segmented on the basis of Product and Application.

Based on Application, the Neuropathic Pain segment is expected to dominate the global market during the forecast period. Pregabalin is recommended as a first-line treatment for diabetic neuropathy, post-herpetic neuralgia, and central neuropathic pain by the European Federation of Neurological Societies. A small number of people profit significantly, whereas a larger number benefit moderately. Burning or shooting pain is a common symptom of neuropathic pain. Nerve injury is the most common cause. The market is expected to grow due to rising incidences of neuropathic pain and rising risk factors such as diabetes and HIV. Furthermore, the patent expiration of Viatris Inc's Lyrica (pregabalin) in 2019 has increased the market share of generic medication producers. Continuous R&D in widening the applications of pregabalin in various disease therapies, as well as new product introductions, are expected to drive market growth. Epilepsy accounted for the highest proportion of the Pregabalin Market application category in 2019 and is expected to increase at a significant rate over the forecasted period. Epilepsy affects approximately 1.2 % of the population in the United States. This equates to around 3.4 million persons in the United States and more than 65 million worldwide. The desire for effective epilepsy therapy is propelling this segment forward. Global Pregabalin Market To know about the Research Methodology :- Request Free Sample Report

Global Pregabalin Market Regional Insights:

Global Pregabalin Market 1

North America is anticipated to hold a dominant market share during forecast years.

Over the forecast period, North America is expected to experience considerable market growth. The rising frequency of chronic diseases, well-established healthcare infrastructure, widespread adoption of new technologies, and government attempts to compel the maintenance of health data all contribute to this increase. Pregabalin is in high demand among the elderly due to the rising frequency of diseases such as neuropathy diabetes and HIV. According to a big American study, 47% of diabetic patients had peripheral neuropathy. At the time of diabetes diagnosis, neuropathy is estimated to be present in 7.5% of patients. Distal symmetric polyneuropathy accounts for more than half of all cases. The report also helps in understanding Global Pregabalin Market dynamics, structure by analyzing the market segments and project the Global Pregabalin Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Pregabalin Market make the report investor’s guide.

Global Pregabalin Market Scope: Inquire before buying

Global Pregabalin Market 2

Global Pregabalin Market, By Region:

• North America • Europe • South America • MEA • APAC

Global Pregabalin Market, Key players:

• Pfizer Inc. • Torrent Pharmaceuticals Ltd. • Lupin Limited • Zydus Cadila Healthcare Ltd. • Cipla Limited • Genesis Remedies • Sanofi • Medley Pharmaceuticals Limited • Genesis Biotec Inc. • Biomax • ZCL Chemicals Ltd. • Olon S.p.A. • AASraw Biochemical Technology Co., Ltd. • Changzhou Pharmaceutical Factory (CPF) • Almelo Pvt. Ltd. • Angels Pharma India Pvt. Ltd. • ARITE Pharmaceutical Co., Ltd. • Bal Pharma Limited. • Bazayan and Co. • Aurobindo Pharma Ltd. • Hikal Ltd. • Glenmark Life Sciences • Dongbang FTL
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Pregabalin Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Pregabalin Market 3.4. Geographical Snapshot of the Pregabalin Market, By Manufacturer share 4. Global Pregabalin Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Pregabalin Market 5. Supply Side and Demand Side Indicators 6. Global Pregabalin Market Analysis and Forecast, 2019-2026 6.1. Global Pregabalin Market Size & Y-o-Y Growth Analysis. 7. Global Pregabalin Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 7.1.1. Capsules 7.1.2. Oral Solutions 7.1.3. Others 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.2.1. Epilepsy 7.2.2. Neuropathic Pain 7.2.3. Anxiety Disorder 7.2.4. Others 8. Global Pregabalin Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Pregabalin Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 9.1.1. Capsules 9.1.2. Oral Solutions 9.1.3. Others 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.2.1. Epilepsy 9.2.2. Neuropathic Pain 9.2.3. Anxiety Disorder 9.2.4. Others 10. North America Pregabalin Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Pregabalin Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12. Canada Pregabalin Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13. Mexico Pregabalin Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14. Europe Pregabalin Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 15. Europe Pregabalin Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Pregabalin Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17. France Pregabalin Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18. Germany Pregabalin Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19. Italy Pregabalin Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20. Spain Pregabalin Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21. Sweden Pregabalin Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22. CIS Countries Pregabalin Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23. Rest of Europe Pregabalin Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24. Asia Pacific Pregabalin Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 25. Asia Pacific Pregabalin Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Pregabalin Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27. India Pregabalin Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28. Japan Pregabalin Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29. South Korea Pregabalin Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30. Australia Pregabalin Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31. ASEAN Pregabalin Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32. Rest of Asia Pacific Pregabalin Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33. Middle East Africa Pregabalin Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 34. Middle East Africa Pregabalin Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Pregabalin Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36. GCC Countries Pregabalin Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37. Egypt Pregabalin Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38. Nigeria Pregabalin Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39. Rest of ME&A Pregabalin Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40. South America Pregabalin Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 41. South America Pregabalin Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Pregabalin Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43. Argentina Pregabalin Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44. Rest of South America Pregabalin Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Pregabalin Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Pfizer Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Torrent Pharmaceuticals Ltd. 45.3.3. Lupin Limited 45.3.4. Zydus Cadila Healthcare Ltd. 45.3.5. Cipla Limited 45.3.6. Genesis Remedies 45.3.7. Sanofi 45.3.8. Medley Pharmaceuticals Limited 45.3.9. Genesis Biotec Inc. 45.3.10. Biomax 45.3.11. ZCL Chemicals Ltd. 45.3.12. Olon S.p.A. 45.3.13. AASraw Biochemical Technology Co., Ltd. 45.3.14. Changzhou Pharmaceutical Factory (CPF) 45.3.15. Almelo Pvt. Ltd. 45.3.16. Angels Pharma India Pvt. Ltd. 45.3.17. ARITE Pharmaceutical Co., Ltd. 45.3.18. Bal Pharma Limited. 45.3.19. Bazayan and Co. 45.3.20. Aurobindo Pharma Ltd. 45.3.21. Hikal Ltd. 45.3.22. Glenmark Life Sciences 45.3.23. Dongbang FTL 46. Primary Key Insights

About This Report

Report ID109027
Category Healthcare
Published DateJune 2021
Updated DateOct 2021
Contact Us